爱尔兰国家糖尿病视网膜病变筛查计划:五轮筛查与筛查阳性转诊报告(INDEAR研究第1号报告)
该回顾性分析基于爱尔兰Diabetic RetinaScreen计划2013年2月至2018年12月的数据,纳入120 048名12岁以上至少参加一次筛查的个体。五轮筛查后,筛查阳性视网膜病变检出率从每10万筛查者13 229降至4 237,增殖性疾病从2 898降至713,而非糖尿病眼病检出转诊从393增至3 225。结论认为筛查阳性视网膜病变转诊检出率下降,但非糖尿病眼病管理是改善糖尿病患者视觉结局的重大挑战。
要点
- 第五轮筛查参与率已达67.2%。
- 筛查阳性视网膜病变检出率五轮间从每10万13 229降至4 237。
- 非糖尿病眼病检出转诊从每10万393增至3 225,增加近八倍。
核心结论
- 五轮筛查后筛查阳性视网膜病变转诊检出率下降,但非糖尿病眼病管理是改善爱尔兰糖尿病患者视觉结局的重大挑战。
研究设计与样本
- 回顾性视网膜病变筛查出席与分级分析,基于社区筛查中心。
- 171 557人被识别为符合年度筛查条件,120 048名12岁以上个体在2013年2月至2018年12月间同意并至少参加一次筛查。
主要发现
- 第五轮筛查参与率已达67.2%。
- 筛查阳性视网膜病变检出率从每10万筛查者13 229降至4 237。
- 增殖性疾病检出率从每10万筛查者2 898降至713。
- 非糖尿病眼病检出并转诊治疗中心从第一轮每10万393增至3 225,增加近八倍。
- 转诊至治疗中心接受眼科医生评估的大多数个体年龄超过50岁。
临床怎么用
- 年度糖尿病视网膜病变筛查中应关注非糖尿病眼病的检出与转诊。
- 转诊至治疗中心接受眼科评估的人群以50岁以上为主。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the uptake of annual diabetic retinopathy screening and study the 5-year trends in the detection of screen-positive diabetic retinopathy and non-diabetes-related eye disease in a cohort of annually screened individuals. DESIGN: Retrospective retinopathy screening attendance and retinopathy grading analysis. SETTING: Community-based retinopathy screening centres for the Diabetic RetinaScreen Programme. PARTICIPANTS: 171 557 were identified by the screening programme to be eligible for annual diabetic retinopathy screening. 120 048 individuals over the age of 12 consented to and attended at least one screening appointment between February 2013 to December 2018. MAIN OUTCOME MEASURES: Detection rate per 100 000 of any retinopathy, screen-positive referrable retinopathy and nondiabetic eye disease. RESULTS: Uptake of screening had reached 67.2% in the fifth round of screening. Detection rate of screen-positive retinopathy reduced from 13 229 to 4237 per 100 000 screened over five rounds. Detection of proliferative disease had reduced from 2898 to 713 per 100 000 screened. Non-diabetic eye disease detection and referral to treatment centres increased almost eightfold from 393 in round 1 to 3225 per 100 000 screened. The majority of individuals referred to treatment centres for ophthalmologist assessment are over the age of 50 years. CONCLUSIONS: Screening programme has seen a reduced detection rate both screen-positive retinopathy referral in Ireland over five rounds of screening. Management of nondiabetic eye diseases poses a significant challenge in improving visual outcomes of people living with diabetes in Ireland.
引用
- Pandey R, Morgan MM, Murphy C, et al. Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1). Br J Ophthalmol. 2020. PMID: 33334818. doi:10.1136/bjophthalmol-2020-317508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。